ECRF DESIGN AND REVIEW SERVICES
BioBoston CRO provides electronic case report form design and review services for sponsors that need protocol-required clinical data translated into clear, usable, standardized, and analysis-aware forms.
Support can include eCRF strategy, complete form design, annotated eCRFs, independent review, amendment impact assessment, field and codelist optimization, or rescue of an inconsistent form package.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
The engagement should be scoped around the current state of the work, the intended decision or milestone, the source package, and the sponsor's approval responsibilities.
Translate objectives, endpoints, eligibility, safety, treatment, visits, and critical processes into a controlled form package before EDC build.
Assess protocol traceability, field necessity, definitions, response options, instructions, standards, usability, analysis needs, and site burden.
Evaluate impacts to fields, visits, codelists, edit checks, existing data, migrations, training, validation, and downstream analyses.
when needed
Problems
The service is most valuable when the team can identify the specific control gap, decision, deliverable, or
recovery need rather than requesting generic capacity.
Scope
The exact scope depends on the maturity of the work, the quality of the inputs, the sponsor’s procedures,
the review model, and the target milestone.
Deliverables
Deliverables should be confirmed at kickoff and linked to defined sponsor decisions, review cycles, and downstream handoffs.
Client inputs
The sponsor does not need every detail finalized before kickoff, but approved decisions, open questions, source owners, reviewers, and deadlines must be distinguishable.
Process
1. Confirm the purpose, current state, intended use, milestone, stakeholders, responsibilities, systems or vendors, and agreed deliverables.
2. Review available source materials, prior decisions, procedures, evidence, and open issues; issue a focused gap and dependency list.
3. Develop the work plan, specifications, document, assessment, or control package included in scope.
4. Coordinate review through named sponsor and cross-functional decision owners and maintain a controlled open-item and comment process.
5. Perform the agreed technical, quality, consistency, or operational checks and document remaining risks or limitations.
6. Prepare the approved handoff, implementation, submission, remediation, archive, or next-step package as defined in scope.
Considerations
The work should remain proportionate to the risk and intended use, follow the sponsor’s controlled process, and preserve clear sponsor decision authority.
Engagement options
BioBoston leads the defined scope from assessment and planning through drafting or execution, review, quality control, and handoff.
BioBoston addresses a specific section, decision, backlog, finding, vendor issue, or stalled deliverable without expanding the engagement unnecessarily.
BioBoston provides an objective second-line review, oversight role, or embedded specialist while the sponsor or another vendor retains primary execution.
RELATED SERVICES
Configure and test the approved eCRFs, fields, visits, logic, roles, edit checks, reports, and interfaces in the EDC.
Define data standards, responsibilities, cleaning, queries, coding, reconciliation, lock, transfer, security, and archive controls.
Confirm endpoint, variable, population, timing, derivation, and output requirements that influence data capture.
Maintain consistency between protocol objectives, endpoints, assessments, procedures, safety requirements, and the complete data-capture package.
Expertise
eCRF experience should match the study design, phase, product, endpoints, data standards, safety and
coding needs, selected EDC, site workflow, external data, and analysis requirements.
RESOURCES
Explore the following resources for additional insights and information relevant to this service.
A planned checklist for protocol traceability, form structure, fields, units, response options, logic, instructions, standards, usability, and downstream use..
A planned tool connecting objectives, endpoints, eligibility, visits, procedures, safety, forms, fields, sources, and reviewers..
A planned checklist for existing data, database configuration, checks, integrations, reports, exports, migration, testing, training, and analysis.
FAQs
Scope may include form strategy, inventory, protocol traceability, form and field design, response options, units, instructions, conditional logic, codelists, annotations, review, amendments, and build interfaces.
Yes. Independent review can assess protocol alignment, field necessity, definitions, standards, usability, site burden, safety, analysis needs, edit-check interfaces, and amendment risk.
No. eCRF design defines the forms and data to be captured. EDC build configures, tests, validates, and releases that approved design in the selected platform.
No. Data collection should be justified by protocol, safety, analysis, regulatory, operational, or quality
needs and consider source availability, site burden, privacy, and downstream use.
Yes. Annotation scope may connect forms and fields to standards, variables, codelists, data specifications,
edit checks, derivations, or other sponsor-defined conventions.
No. Good design can reduce ambiguity and avoidable burden, but queries may still arise from source data, site conduct, missing information, protocol complexity, external data, and legitimate review needs.
PROJECT FORM
Share the study, protocol and schedule-of-assessments status, current eCRF stage, standards, selected EDC, build timeline, and principal design or usability concerns. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the protocol, endpoints, visits, current forms, standards, EDC, data and analysis needs, reviewers, and build timeline. BioBoston can then define the design, independent review, annotation, or amendment scope.
